The following article was originally posted in Drug Channels on WETM TV 18’s website, https://www.mytwintiers.com, on December 10, 2020. Trillium Health is an RWC-340B Sustaining
On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B product
Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health and
By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at contract
Please join us for the Community Voices for 340B and Ryan White Clinics for 340B Access’ National Advocacy Webinar
RSVP by clicking HERE.
Webinar Description
The National Advocacy
The following article highlighting the RWC-340B Reduction in Resources White Paper was posted on the PR Newswire website on October 26, 2020. Sentry Data Systems,
The following article highlighting the Association for Value-Based Cancer Care 2020 Summit was posted on the AVBCC website on October 20, 2020
On October 8, 2020,
On October 9, 2020, RWC-340B and two of its member 340B grantee clinics, Cempa Community Cares and Matthew 25 AIDS Services, Inc., filed a lawsuit
The following editorial from Shannon Stephenson, CEO of Cempa Community Care, President of RWC-340B was posted in Drug Channels on October 9, 2020
Manufacturers and covered
The following editorial from Mike Lee, COO of Evergreen Health, Secretary of RWC-340B was posted in the New York Daily News on September 16, 2020
Over
